StonvexLoading…
StonvexStonvexStonvexCore line items from FCX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $25.19B | $25.17B | $22.70B | $23.27B |
Operating Income | $6.52B | $6.86B | $6.22B | $7.04B |
Net Income | $4.15B | $4.40B | $3.75B | $4.48B |
EPS (Diluted) | $1.52 | $1.30 | $1.28 | $2.39 |
Total Assets | $58.17B | $54.85B | $52.51B | $51.09B |
Total Liabilities | $27.40B | $26.07B | $25.20B | $26.22B |
Cash & Equivalents | $3.82B | $3.92B | $4.76B | $8.15B |
Free Cash Flow OCF − CapEx | $1.12B | $2.35B | $455.00M | $1.67B |
Shares Outstanding | 1.44B | 1.45B | 1.44B | 1.45B |